(Q34088944)

30 July 2017

1 reference

title

The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder (English)

1 reference

30 July 2017

0 references

1 reference

Roosmarijn C Drexhage

1

1 reference

30 July 2017

Esther M Knijff

2

1 reference

30 July 2017

Roos C Padmos

3

1 reference

30 July 2017

Leonie van der Heul-Nieuwenhuijzen

4

1 reference

30 July 2017

Wouter Beumer

5

1 reference

30 July 2017

Marjan A Versnel

6

1 reference

30 July 2017

Hemmo A Drexhage

7

1 reference

30 July 2017

publication date

1 January 2010

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

30 July 2017

published in

1 reference

30 July 2017

volume

10

1 reference

30 July 2017

issue

1

1 reference

30 July 2017

page(s)

59-76

1 reference

A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes.

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

A comprehensive macrophage-T-lymphocyte theory of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

The macrophage-T-lymphocyte theory of schizophrenia: Additional evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Microglial control of neuronal death and synaptic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Association between the A-2518G polymorphism in the monocyte chemoattractant protein-1 gene and insulin resistance and Type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Dendritic cells and macrophages in the pituitary and the gonads. Evidence for their role in the fine regulation of the reproductive endocrine response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

A functional and phenotypic study on immune accessory cells isolated from the thyroids of Wistar and autoimmune-prone BB-DP rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Antigen-presenting dendritic cells as regulators of the growth of thyrocytes: a role of interleukin-1beta and interleukin-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Microglia in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Developmental neuronal death in hippocampus requires the microglial CD11b integrin and DAP12 immunoreceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Regulatory T cells and immune tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Aging and proinflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

21 January 2018

Gender and autoimmunity

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Racial variation in serum-soluble interleukin-2 receptor levels: a population-based study of healthy smokers and nonsmokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Exposure-dependent effects of ethanol on the innate immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

A unique role of monocyte chemoattractant protein 1 among chemokines in adipose tissue of obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Prevalence of diabetes mellitus in chronic schizophrenic inpatients in relation to long-term antipsychotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Carotid intima-media thickness and coronary atherosclerosis: weak or strong relations?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Cytokines in schizophrenia and the effects of antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

The interaction of nuclear factor-kappa B and cytokines is associated with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Serum IL-1beta, sIL-2R, IL-6, IL-8 and TNF-alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Cytokine changes and tryptophan metabolites in medication-naïve and medication-free schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Postoperative confusion in schizophrenic patients is affected by interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

High-quality remission: potential benefits of the melatonergic approach for patients with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Increased tumor necrosis factor-alpha concentrations with interleukin-4 concentrations in exacerbations of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Plasma levels of interleukin-6 and tumor necrosis factor alpha in chronic schizophrenia: effects of clozapine treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Cytokine profiles in bipolar affective disorder: focus on acutely ill patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Th1, Th2 and Th3 cytokine alteration in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Interleukin-12 plasma levels in drug-naïve patients with a first episode of psychosis: effects of antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Immunological dysfunction in schizophrenia: a systematic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

The leukocytes expressing DARPP-32 are reduced in patients with schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Expression of neuronal calcium sensor-1 (NCS-1) is decreased in leukocytes of schizophrenia and bipolar disorder patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Cortisol and cytokines in chronic and treatment-resistant patients with schizophrenia: association with psychopathology and response to antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Increased levels of CD8+ and CD4+ 45RA+ lymphocytes in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Altered T-cell function in schizophrenia: a cellular model to investigate molecular disease mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Superoxide dismutase and cytokines in chronic patients with schizophrenia: association with psychopathology and response to antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Increased frequency of CD8 positive gamma/delta T-lymphocytes (CD8+ gamma/delta+) in unmedicated schizophrenic patients: relation to impairment of the blood-brain barrier and HLA-DPA*02011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

The relationship of depression and stressors to immunological assays: a meta-analytic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Absence of neurodegeneration and neural injury in the cerebral cortex in a sample of elderly patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Expression of CD40 in the brain of Alzheimer's disease and other neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Absence of neurodegeneration in the thalamus and caudate of elderly patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Elevation of cell adhesion molecule immunoreactivity in the anterior cingulate cortex in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

[11C]-DPA-713 and [18F]-DPA-714 as new PET tracers for TSPO: a comparison with [11C]-(R)-PK11195 in a rat model of herpes encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Rolipram in major depressive disorder: results of a double-blind comparative study with imipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

The effect of tumor necrosis factor antagonists on mood and mental health-associated quality of life: novel hypothesis-driven treatments for bipolar depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Spatial arrangement of microglia in the mouse hippocampus: a stereological study in comparison with astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

S100B in neuropathologic states: the CRP of the brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Genetic and environmental influences on pro-inflammatory monocytes in bipolar disorder: a twin study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Distinct monocyte gene-expression profiles in autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

The main function of IL-2 is to promote the development of T regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Celecoxib as adjunctive therapy in schizophrenia: a double-blind, randomized and placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

The phosphodiesterase inhibitors pentoxifylline and rolipram suppress macrophage activation and nitric oxide production in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Neuropsychiatric side effects of HCV therapy and their treatment: focus on IFN alpha-induced depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

Immune variations in bipolar disorder: phasic differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.144

21 January 2018

Identifiers

DOI

10.1586/ERN.09.144

1 reference

30 July 2017

1 reference